You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
9 September 2024
Abivax presents first-half 2024 financial results
6 August 2024
Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
15 July 2024
Abivax Provides Operational and Key Program Update
5 April 2024
Abivax publishes financial reports with the French and U.S. securities regulatory agencies
2 April 2024
Abivax reports 2023 financial results and operational update
13 February 2024
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)